Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 2/20 | 0.36 |
| ▸ | CTSK | P43235 | 7/20 | 0.36 |
| ▸ | CTSS | P25774 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15928599 | 0.89 | CTSL (0.39) | CTSLDPP4CTSKCTSSALDH1A1 | |
| SCHEMBL2394821 | 0.76 | CTSL (0.59) | CTSLCTSKCTSSKMT2A | |
| SCHEMBL10144371 | 0.76 | DPP4 (0.34) | DPP4 | |
| SCHEMBL15928425 | 0.74 | KMT2A (0.36) | CTSKALDH1A1KMT2ACACNA1BEPHX2 | |
| SCHEMBL1586413 | 0.74 | CTSL (0.53) | CTSLCTSKCTSSKMT2A | |
| SCHEMBL15928448 | 0.73 | KMT2A (0.35) | CTSKALDH1A1KMT2ACACNA1BEPHX2 | |
| SCHEMBL26938697 | 0.72 | DRD2 (0.42) | CTSKALDH1A1KMT2A | |
| SCHEMBL15928671 | 0.72 | EPHX2 (0.36) | CTSKCTSSALDH1A1KMT2AEPHX2 | |
| SCHEMBL17518905 | 0.72 | EPHX2 (0.36) | CTSKCTSSALDH1A1KMT2AEPHX2 | |
| SCHEMBL26938695 | 0.72 | DRD2 (0.42) | CTSKALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010088167-A1 | BRIDGED COMPOUNDS AS HIV INTEGRASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2010-08-05 | — | — | WO | disclosed |